The Biden administration on Thursday asserted its authority to seize the patents of certain costly medications in a new push to slash high drug prices and promote more pharmaceutical competition.

The administration unveiled a framework outlining the factors federal agencies should consider in deciding whether to use a controversial policy, known as march-in rights, to break the patents of drugs that were developed with federal funds but are not widely accessible to the public. For the first time, officials can now factor in a medication’s price — a change that could have big implications for drugmakers depending on how the government uses the powers.

“When drug companies won’t sell taxpayer-funded drugs at reasonable prices, we will be prepared to allow other companies to provide those drugs for less,” White House National Economic Advisor Lael Brainard said during a call with reporters Wednesday.

  • Brokkr@lemmy.world
    link
    fedilink
    arrow-up
    0
    ·
    11 months ago

    They do great work, but they don’t market and promote their successes well enough. I would prefer a society that favors humility more and therefore appreciate this administration’s style, but it seems that a lack of hubris is now considered a fault in the public eye, on both sides of the aisle.

    • BigMacHole@lemm.ee
      link
      fedilink
      arrow-up
      0
      arrow-down
      1
      ·
      11 months ago

      I would like an administration whose flamboyant about their successes so I know what to expect in my daily life when it comes to politics aka why I see more EVs (rebates funding and a federal charging grid), lower/higher prices on things (like Biden removing patents to create competition) and even insurrectionists going to jail (if we had a working justice system)!